Ariella’s Immunotherapy Story: Getting Her Life Back After Hodgkin Lymphoma

Ariella’s Immunotherapy Story: Getting Her Life Back After Hodgkin Lymphoma

Diagnosed with Hodgkin lymphoma while in college, Ariella Chivil completed standard treatment for the disease, and hoped to put it behind her. Unfortunately, the cancer returned. After trying 14 different cancer treatments, Ariella enrolled in an immunotherapy clinical trial for the drug nivolumab (Opdivo). On May 17, 2016, Opdivo was FDA-approved for the treatment of Hodgkin lymphoma.
For more information, visit CancerResearch.org.